Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00482196 | To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED) | PHASE2 | COMPLETED | 173 | — | — | Jul 1, 2005 | Mar 1, 2006 | Apr 28, 2015 | - | — |
| NCT00482638 | Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED) | PHASE2 | COMPLETED | - | — | — | May 12, 2004 | Oct 29, 2004 | Nov 14, 2019 | - | — |
| Name | Type | Description |
|---|---|---|
| MK0493 | DRUG | - |
Inclusion Criteria: * Patient is between 21 and 65 years of age Exclusion Criteria: * HIV positive as determined by medical history * Patient is pregnant, lactating or plans to become pregnant * Patient has undergone surgical treatment for obesity * Patient has undergone a surgical procedure with...